Glioblastoma

Proper planning is essential for protecting assets in the event of divorce, according to attorney David B. Mandell, JD, MBA. His financial guide concerning divorce was the top story in hematology/oncology last week.

Morning administration of temozolomide appeared associated with longer OS compared with evening administration among patients with newly diagnosed glioblastoma, according to study results published in Neuro-Oncology Advances.

The FDA granted orphan drug designation to CYNK-001 for the treatment of malignant gliomas, according to the agent’s manufacturer.

The FDA granted fast track designation to GLR2007 for treatment of glioblastoma, according to the agent’s manufacturer.

The FDA granted fast track designation to several agents under investigation for the treatment of patients with certain solid tumors or hematologic malignancies.

A personalized cancer vaccine improved PFS compared with historical outcomes with standard-of-care treatment for patients with newly diagnosed glioblastoma, according to phase 2 study results.

City of Hope announced it has reached an agreement with Australia-based biotech Chimeric Therapeutics.

A novel blood-based assay demonstrated the ability to detect five cancer types up to 4 years earlier than current screening methods, according to a recent study. It was the top story in hematology/oncology last week.

The FDA granted orphan drug designation to rhenium nanoliposomes for the treatment of patients with recurrent glioblastoma, according to a manufacturer-issued press release.

The FDA granted fast track designation to paxalisib for the treatment of patients with newly diagnosed glioblastoma, according to a manufacturer-issued press release.